---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-384363"
form_type: "8-K"
ticker: "KURA"
cik: "0001422143"
company_name: "Kura Oncology, Inc."
filed_at: "2026-09-08T11:05:06+00:00"
generated_at: "2026-09-08T11:10:56.945946+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Kura Oncology appoints Jennifer Fulk as CFO and principal accounting officer

## Summary
- Effective Sept 8, 2026, Jennifer Fulk appointed CFO, principal financial and principal accounting officer.
- Fulk replaces Troy E. Wilson as CFO and Thomas Doyle as principal accounting officer.
- Compensation: $550,000 base salary, up to 45% bonus, option for 450,000 shares, PSU for 173,438 shares.
- Prior roles: CFO Soleno Therapeutics, COO/CFO 120Water, CFO Talkspace, 15+ years at Eli Lilly.
- Severance includes 12-18 months salary, COBRA, and equity acceleration in change of control.

## SEC filing metadata
- accession: 0001193125-26-384363
- form_type: 8-K
- ticker: KURA
- cik: 0001422143
- company_name: Kura Oncology, Inc.
- filed_at: 2026-09-08T11:05:06+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1422143/000119312526384363/0001193125-26-384363-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1422143/000119312526384363/d458603d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-384363
- JSON: https://secwatch.observer/filing/0001193125-26-384363.json
- Plain text: https://secwatch.observer/filing/0001193125-26-384363.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.